单位:[1]Huazhong Univ Sci & Technol,Tongji Hosp,Dept GI Canc Res Inst,Tongji Med Coll,Wuhan,Hubei,Peoples R China胃肠肿瘤研究所华中科技大学同济医学院附属同济医院外科学系胃肠外科[2]Wake Forest Univ, Wake Forest Baptist Med Ctr, Dept Canc Biol, Winston Salem, NC 27109 USA[3]Guangzhou Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China[4]Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA[5]Univ Arkansas Med Sci, Coll Pharm, Dept Pharmaceut Sci, Little Rock, AR 72205 USA[6]China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan[7]Asia Univ, Dept Biotechnol, Taichung, Taiwan
The serine/threonine kinase Akt plays a central role in cell proliferation, survival and metabolism, and its hyperactivation is linked to cancer progression. Here we report that Akt undergoes K64 methylation by SETDB1, which is crucial for cell membrane recruitment, phosphorylation and activation of Akt following growth factor stimulation. Furthermore, we reveal an adaptor function of histone demethylase JMJD2A, which is important for recognizing Akt K64 methylation and recruits E3 ligase TRAF6 and Skp2-SCF to the Akt complex, independently of its demethylase activity, thereby initiating K63-linked ubiquitination, cell membrane recruitment and activation of Akt. Notably, the cancer-associated Akt mutant E17K displays enhanced K64 methylation, leading to its hyper-phosphorylation and activation. SETDB1-mediated Akt K64 methylation is upregulated and correlated with Akt hyperactivation in non-small-cell lung carcinoma (NSCLC), promotes tumour development and predicts poor outcome. Collectively, these findings reveal complicated layers of Akt activation regulation coordinated by SETDB1-mediated Akt K64 methylation to drive tumorigenesis.
基金:
National Cancer Institute's Cancer Center Support Grant [P30CA012197]; Wake Forest School of Medicine, NIH [R01CA182424, R01CA193813]; NIH [R01CA207098, R01CA207109, RO1CA194094, RO1CA197178]; Wake Forest Baptist Comprehensive Cancer Center; Cellular Imaging & flow cytometry Shared of Resource
第一作者单位:[1]Huazhong Univ Sci & Technol,Tongji Hosp,Dept GI Canc Res Inst,Tongji Med Coll,Wuhan,Hubei,Peoples R China[2]Wake Forest Univ, Wake Forest Baptist Med Ctr, Dept Canc Biol, Winston Salem, NC 27109 USA
通讯作者:
通讯机构:[2]Wake Forest Univ, Wake Forest Baptist Med Ctr, Dept Canc Biol, Winston Salem, NC 27109 USA[6]China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan[7]Asia Univ, Dept Biotechnol, Taichung, Taiwan
推荐引用方式(GB/T 7714):
Wang Guihua,Long Jie,Gao Yuan,et al.SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis[J].NATURE CELL BIOLOGY.2019,21(2):214-+.doi:10.1038/s41556-018-0266-1.
APA:
Wang, Guihua,Long, Jie,Gao, Yuan,Zhang, Weina,Han, Fei...&Lin, Hui-Kuan.(2019).SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis.NATURE CELL BIOLOGY,21,(2)
MLA:
Wang, Guihua,et al."SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis".NATURE CELL BIOLOGY 21..2(2019):214-+